Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum
Movement Disorders Clinical Practice · 2026
DOI: 10.1002/mdc3.70288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2026. Verfasst von Japleen Kaur und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of neuroscience, UC San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: Huntington Disease, Postural Balance, Sensation Disorders. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutation in the huntingtin gene on chromosome 4, leading to progressive cognitive decline, motor impairment, and functional disability. Although balance impairment is recognized in HD, its onset and evolution with disease stage remain poorly understood.
Objective
The aim was to track the onset and evolution of balance impairment in HD with progression of disease stage using the BTrackS Balance Plate.
Methods
Total body sway (TBS) was assessed in 123 gene‐positive participants and 33 healthy controls (HC) using the BTrackS Balance Plate and laptop software. The prognostic index–derived Huntington's Disease Integrated Staging System (HD‐ISS) was used to stratify these subjects into stage 0/1 (n = 51), stage 2 (n = 38), and Stage 3 (n = 34). Nonparametric receiver operating characteristic curve analysis was used to compute optimal cutoff values for TBS.
Results
Balance assessment revealed significant differences in TBS between HCs and gene‐positive participants ( P < 0.001). TBS varied significantly across disease stages ( P < 0.001), with mean values of 9.56 cm (stage 0/1), 14.46 cm (stage 2), and 28.26 cm (Stage 3). The comparison between HCs and stage 0/1 individuals revealed strong discrimination (area under the curve [AUC] = 0.709), with a threshold of 7.72 cm achieving 74.5% sensitivity. The most robust discrimination emerged between stage 2 and Stage 3 participants (AUC = 0.71), with a threshold of 11.85 cm at 82.4% sensitivity.
Conclusions
In conclusion, this cross‐sectional study demonstrates that balance impairment is an early and progressive feature of HD, detectable even before the onset of overt motor symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of neuroscience, UC San Diego, San Diego, California, USA.
- Department of Psychology, San Diego State University, San Diego, California, USA.
- Exercise Science, Oakland University, Rochester, Michigan, USA.
ORCID-Profile: Japleen Kaur, Krisha Bagga
Zitieren
APA
Kaur, J., Youhanan, N., Bagga, K., Hall, A., Gilbert, P. E., Goble, D. J., & Corey-Bloom, J. (2026). Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70288
Vancouver
Kaur J, Youhanan N, Bagga K, Hall A, Gilbert PE, Goble DJ, et al. Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70288
BibTeX
@article{Kaur2026,
author = {Kaur, Japleen and Youhanan, Nadeen and Bagga, Krisha and Hall, Andrew and Gilbert, Paul E and Goble, Daniel J and Corey-Bloom, Jody},
title = {Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum},
journal = {Movement Disorders Clinical Practice},
year = {2026},
doi = {10.1002/mdc3.70288}
}
EUVIMED